The Karlsburg Diabetes Management System: Translation from Research to eHealth Application

Salzsieder, Eckhard; Augstein, Petra

doi:10.1177/193229681100500103

Cited by 29 publications

(32 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…28 Only a few articles addressing cost-effectiveness of telecare in diabetes are available. In addition to the two above-mentioned reports, 27,28 information on costs and savings are presented by Chase et al, 29 Biermann et al, 30 and Cherry et al 31 Chase et al 29 29 pointed out that they could not be extended automatically beyond the time frame of the study, which equaled 6 months.…”

Section: Discussionmentioning

confidence: 99%

What We Can Really Expect from Telemedicine in Intensive Diabetes Treatment: 10 Years Later

Wójcicki

Ładyżyński²,

Foltynski³

2013

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

During the last 10 years many new telematic systems aiming at support of diabetes treatment have been designed and developed. Most systems that were applied in clinical randomized trials used the classical approach, with data transfers from patients performed usually once every few days. In the few available meta-analyses of these trials, a significant improvement of the mean hemoglobin A1c was demonstrated in patients using telematic systems. However, the magnitude of this improvement in comparison with the control groups was lower than expected. This conclusion was confirmed by results of the IDEATel study involving more than 1,600 patients over a period of 5 years. It might by hypothesized that in some groups of patients continuous telecare with frequent contacts between patients and the care provider during each day should be required. This hypothesis is confirmed by the results of the clinical trials applying real-time diabetes monitoring systems. However, the increased frequency of the data transfers and checkups requires a new model for technology-supported care. The new model should connect together the ubiquitous data transfer with an automatically selected optimal frequency, the automatic assessment of the data coupled with quicker feedback from the decision support system or from the provider, and selection of the optimal time for the patient's face-to-face visit in the clinic. All this new future implementations together with already confirmed advantages of the telematic support, such as the increase of self-confidence of the patient, will hopefully give real benefits for the patients.

show abstract

Section: Discussionmentioning

confidence: 99%

What We Can Really Expect from Telemedicine in Intensive Diabetes Treatment: 10 Years Later

Wójcicki

Ładyżyński²,

Foltynski³

2013

Diabetes Technology & Therapeutics

View full text Add to dashboard Cite

show abstract

“…The survey focused on the acceptance of the system by the physicians who provided care for these patients. 26 The second component was a retrospective analysis of data for a subset of 289 patients who completed two glucose monitoring sessions during 1 year.…”

Section: Telemedicine For Diabetes Managementmentioning

confidence: 99%

The Empirical Evidence for the Telemedicine Intervention in Diabetes Management

Bashshur

Shannon

Smith

et al. 2015

Telemedicine and e-Health

View full text Add to dashboard Cite

Objective: The research presented here assesses the scientific evidence for the telemedicine intervention in the management of diabetes (telediabetes), gestational diabetes, and diabetic retinopathy. The impetus derives from the confluence of high prevalence of these diseases, increasing incidence, and rising costs, while telemedicine promises to ameliorate, if not prevent, type 2 diabetes and its complications. Materials and Methods: A purposeful review of the literature identified relevant publications from January 2005 to December 2013. These were culled to retain only credible research articles for detailed review and analysis. The search yielded approximately 17,000 articles with no date constraints. Of these, 770 appeared to be research articles within our time frame. A review of the abstracts yielded 73 articles that met the criteria for inclusion in the final analysis. Evidence is organized by research findings regarding feasibility/acceptance, intermediate outcomes (e.g., use of service, and screening compliance), and health outcomes (control of glycemic level, lipids, body weight, and physical activity.) Results: Definitions of telediabetes varied from study to study vis-à-vis diabetes subtype, setting, technology, staffing, duration, frequency, and target population. Outcome measures also varied. Despite these vagaries, sufficient evidence was obtained from a wide variety of research studies, consistently pointing to positive effects of telemonitoring and telescreening in terms of glycemic control, reduced body weight, and increased physical exercise. The major contributions point to telemedicine's potential for changing behaviors important to diabetes control and prevention, especially type 2 and gestational diabetes. Similarly, screening and monitoring for retinopathy can detect symptoms early that may be controlled or treated. Conclusions: Overall, there is strong and consistent evidence of improved glycemic control among persons with type 2 and gestational diabetes as well as effective screening and monitoring of diabetic retinopathy.

show abstract

“…Se han desarrollado proyectos sobre laboratorios [22][23][24][25] , diabetes 26,27 , anticoagulació n 28 , pacientes respiratorios 29,30 , problemas cardiacos 31,32 , enfermedades infecciosas 33,34 , anatomía patoló gica 35 , radiología 36,37 e incluso terapias en 3-D en psicología clínica 38 .…”

Section: Telemedicinaunclassified

Nuevas herramientas en salud

Herrera

Gascón

2012

Medicina Clínica

View full text Add to dashboard Cite

The Karlsburg Diabetes Management System: Translation from Research to eHealth Application

Cited by 29 publications

References 24 publications

What We Can Really Expect from Telemedicine in Intensive Diabetes Treatment: 10 Years Later

What We Can Really Expect from Telemedicine in Intensive Diabetes Treatment: 10 Years Later

The Empirical Evidence for the Telemedicine Intervention in Diabetes Management

Nuevas herramientas en salud

Contact Info

Product

Resources

About